New blood markers for predicting no-reflow after heart attack treatment
Part of Heart & circulation clinical trials.
This study tests if certain blood markers can predict a complication called no-reflow (when blood doesn't flow well after opening a blocked artery) in patients having emergency heart artery treatment (PCI). This could help doctors identify and manage this risk early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had a type of heart attack called STEMI and are getting emergency artery-opening treatment (PCI).
- You have not had a previous heart attack, previous artery-opening procedure (PCI), or bypass surgery (CABG).
- You do not have a long-term inflammatory or autoimmune disease (like rheumatoid arthritis or lupus).
- You do not have severe kidney or liver failure, active infection, or active cancer.
- You agree to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood test “markers” soon after an acute heart attack, to better understand heart damage and whether heart failure is present. It may help doctors improve how they monitor recovery and risk in people after a heart attack.
This study looks at whether giving medication before the heart procedure can reduce tiny blood-vessel blockages (and “no-flow” areas) after a certain type of heart attack. It may help improve heart blood flow right after treatment in people who meet specific procedure and timing criteria.
This study looks at how insulin resistance affects blood flow after a common heart attack procedure (stenting) in people with type 2 diabetes. It may help doctors understand why some patients have poor blood flow after treatment.
This study is looking for people who have had a heart attack or have heart failure to discover new markers in your blood that could help doctors better understand and treat heart disease. By collecting samples and health data, researchers hope to find clues that improve care for future patients.
This study is checking if a simple blood test (hs-CRP to albumin ratio) can help predict outcomes in people who have had a heart attack or unstable angina but are not getting an immediate balloon/stent procedure. It aims to use inflammation markers to guide better care.
This study is checking if two simple, inexpensive blood tests (NLR and CRP) can help predict how well someone with a certain type of heart attack (STEMI) will do. It aims to find a cheaper way to guide treatment and monitor recovery.
Hear when a new No-Reflow Phenomenon trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.